Formulations of paclitaxel. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy3

Cell Line, Tumor Microtubules Tumor Cells, Cultured

Organisms3

Taxus Mice, Nude Mice, Inbred BALB C

Diseases15

Ovarian Neoplasms Lung Neoplasms Breast Neoplasms Carcinoma, Non-Small-Cell Lung Neutropenia Neoplasms Peripheral Nervous System Diseases Fallopian Tube Neoplasms Leukopenia Peritoneal Neoplasms Neoplasms, Glandular and Epithelial Thrombocytopenia Hematologic Diseases Carcinoma Adenocarcinoma

Chemicals and Drugs65

Paclitaxel Antineoplastic Agents, Phytogenic Carboplatin Delayed-Action Preparations Excipients Drug Carriers Tablets Dosage Forms Pharmaceutical Vehicles Tubulin Modulators Cisplatin Emulsions Antineoplastic Agents Capsules Taxoids Doxorubicin Bridged Compounds Liposomes Powders Polyethylene Glycols Pharmaceutical Solutions Tubulin Epothilones Deoxycytidine Methylcellulose Suspensions P-Glycoprotein Polysorbates Polymers Micelles Surface-Active Agents Emulsifying Agents Topotecan Epirubicin Vinblastine Polyglycolic Acid Drug Combinations Gels Poloxamer Nanocapsules Antibodies, Monoclonal, Humanized Chitosan Pharmaceutical Preparations Cyclophosphamide Albumins Castor Oil Ifosfamide Fluorouracil Antibiotics, Antineoplastic Glycerol Polyglutamic Acid Granulocyte Colony-Stimulating Factor Radiation-Sensitizing Agents Platinum Compounds Preservatives, Pharmaceutical Estramustine Carboxymethylcellulose Sodium Polymethacrylic Acids Etoposide Antibodies, Monoclonal Amphotericin B Ointments Aluminum Hydroxide Cyclosporins Solvents

Analytical, Diagnostic and Therapeutic Techniques and Equipment37

Antineoplastic Combined Chemotherapy Protocols Delayed-Action Preparations Drug Compounding Drug Administration Schedule Drug Carriers Dosage Forms Pharmaceutical Vehicles Drug Delivery Systems Drug Stability Infusions, Intravenous Technology, Pharmaceutical Treatment Outcome Area Under Curve Administration, Oral Maximum Tolerated Dose Disease-Free Survival Freeze Drying Survival Analysis Combined Modality Therapy Xenograft Model Antitumor Assays Administration, Topical Survival Rate Drug Storage Drug Screening Assays, Antitumor Neoplasm Staging Nanocapsules Chromatography, High Pressure Liquid Administration, Cutaneous Inhibitory Concentration 50 Cross-Over Studies Feasibility Studies Calorimetry, Differential Scanning Microspheres Injections, Intravenous Chemotherapy, Adjuvant Drug Evaluation, Preclinical Neoplasm Transplantation

Phenomena and Processes19

Drug Resistance, Neoplasm Particle Size Dose-Response Relationship, Drug Biological Availability Area Under Curve Solubility Therapeutic Equivalency Drug Synergism Skin Absorption Maximum Tolerated Dose Time Factors Apoptosis Drug Resistance, Multiple Cell Survival Tissue Distribution Inhibitory Concentration 50 Drug Interactions Viscosity Cell Proliferation

Disciplines and Occupations2

Chemistry, Pharmaceutical Technology, Pharmaceutical

Technology, Industry, Agriculture11

Nanoparticles Technology, Pharmaceutical Liposomes Polyethylene Glycols Polysorbates Polymers Polyglycolic Acid Poloxamer Nanocapsules Polymethacrylic Acids Nanostructures

Information Science1

Health Care7

Treatment Outcome Area Under Curve Disease-Free Survival Survival Analysis Survival Rate Cross-Over Studies Feasibility Studies

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Information Science Health Care

Paclitaxel Antineoplastic Agents, Phytogenic Chemistry, Pharmaceutical Antineoplastic Combined Chemotherapy Protocols Carboplatin Delayed-Action Preparations Drug Compounding Excipients Drug Administration Schedule Drug Carriers Tablets Dosage Forms Pharmaceutical Vehicles Ovarian Neoplasms Drug Delivery Systems Tubulin Modulators Drug Stability Infusions, Intravenous Nanoparticles Technology, Pharmaceutical Drug Resistance, Neoplasm Cisplatin Particle Size Emulsions Dose-Response Relationship, Drug Treatment Outcome Biological Availability Antineoplastic Agents Area Under Curve Capsules Taxoids Doxorubicin Lung Neoplasms Breast Neoplasms Administration, Oral Solubility Bridged Compounds Therapeutic Equivalency Cell Line, Tumor Liposomes Carcinoma, Non-Small-Cell Lung Neutropenia Powders Taxus Polyethylene Glycols Pharmaceutical Solutions Tubulin Epothilones Drug Synergism Deoxycytidine Skin Absorption Maximum Tolerated Dose Methylcellulose Suspensions Disease-Free Survival Freeze Drying P-Glycoprotein Polysorbates Polymers Neoplasms Mice, Nude Survival Analysis Micelles Surface-Active Agents Emulsifying Agents Topotecan Peripheral Nervous System Diseases Epirubicin Fallopian Tube Neoplasms Microtubules Vinblastine Time Factors Combined Modality Therapy Xenograft Model Antitumor Assays Polyglycolic Acid Tumor Cells, Cultured Drug Combinations Apoptosis Administration, Topical Survival Rate Drug Resistance, Multiple Gels Drug Storage Poloxamer Drug Screening Assays, Antitumor Neoplasm Staging Nanocapsules Cell Survival Chromatography, High Pressure Liquid Antibodies, Monoclonal, Humanized Chitosan Pharmaceutical Preparations Administration, Cutaneous Cyclophosphamide Albumins Castor Oil Leukopenia Tissue Distribution Inhibitory Concentration 50 Peritoneal Neoplasms

No FAQ available that match "formulations of paclitaxel"